Commission Regulation (EC) No 1055/2006 of  12 July 2006  amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards flubendazole and lasalocid   (Text with EEA relevance)
Date: 2006-07-12
Institutions: European Commission
Subjects: animal product, chemical product, material of animal origin, veterinary drug, veterinary legislation

13.7.2006

EN

Official Journal of the European Union

L 192/3

COMMISSION REGULATION (EC) No 1055/2006

of 12 July 2006

amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community
procedure for the establishment of maximum residue limits of veterinary medicinal products in
foodstuffs of animal origin, as regards flubendazole and lasalocid

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Regulation (EEC) No 2377/90 of 26
June 1990 laying down a Community procedure for the estab-
lishment of maximum residue limits of veterinary medicinal
products in foodstuffs of animal origin (1), and in particular
Article 2 and the third paragraph of Article 4 thereof,

skin and fat,
liver and kidney, excluding animals from
which eggs are produced for human consumption. The
substance lasalocid should be included in Annex III to
that Regulation for poultry from which eggs
are
produced for human consumption, awaiting validation
current
of
provision,
are
produced for human consumption, should be deleted
from the entry of lasalocid in Annex I to Regulation
(EEC) No 2377/90.

analytical methods. Consequently

from which eggs

excluding animals

the

(4)

Regulation (EEC) No 2377/90 should therefore be
amended accordingly.

Having regard to the opinions of
the European Medicines
Agency formulated by the Committee for Medicinal Products
for Veterinary Use,

(5)

Whereas:

(1)

(2)

All pharmacologically active substances used in the
Community in veterinary medicinal products intended
for
should be evaluated in
accordance with Regulation (EEC) No 2377/90.

food-producing animals

(6)

The substance flubendazole is currently included in
Annex I to Regulation (EEC) No 2377/90 for chicken,
turkey, game birds and porcine for muscle, skin and fat,
liver and kidney as well as for chicken from which eggs
are produced for human consumption. The entry for
flubendazole in that Annex should be extended to all
poultry species for muscle, skin and fat,
liver, kidney
and eggs.

An adequate period should be allowed before the appli-
cability of this Regulation in order to enable Member
States to make any adjustment which may be necessary
in the light of this Regulation to the authorisations to
place the veterinary medicinal products concerned on the
market which have been granted in accordance with
Directive 2001/82/EC of the European Parliament and
the Council of 6 November 2001 on the
of
Community
to veterinary medicinal
products (2) to take account of the provisions of this
Regulation.

relating

code

The measures provided for in this Regulation are in
accordance with
Standing
the
the
Committee on Veterinary Medicinal Products,

opinion

of

HAS ADOPTED THIS REGULATION:

(3)

The substance lasalocid is currently included in Annex I
to Regulation (EEC) No 2377/90 for poultry for muscle,

Article 1

Annexes I and III to Regulation (EEC) No 2377/90 are amended
in accordance with the Annex to this Regulation.

(1) OJ L 224, 18.8.1990, p. 1. Regulation as

last amended by
Commission Regulation (EC) No 205/2006 (OJ L 34, 7.2.2006,
p. 21).

(2) OJ L 311, 28.11.2001, p. 1. Directive as last amended by Directive

2004/28/EC (OJ L 136, 30.4.2004, p. 58).

L 192/4

EN

Official Journal of the European Union

13.7.2006

This Regulation shall enter into force on the third day following its publication in the Official Journal of the
European Union.

Article 2

It shall apply from 11 September 2006.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 12 July 2006.

For the Commission

Günter VERHEUGEN
Vice-President

13.7.2006

EN

Official Journal of the European Union

L 192/5

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

i

s
e
l
o
z
a
d
m
i
z
n
e
b
-
o
r
p

d
n
a

i

s
e
l
o
z
a
d
m
i
z
n
e
B

.

.

3
1
2

.

X
E
N
N
A

:
)
d
e
x
i
f

n
e
e
b

e
v
a
h

s
t
i

m

i
l

e
u
d
i
s
e
r

m
u
m
i
x
a
m

h
c
i
h
w

r
o
f

s
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
p

f
o

t
s
i
L
(

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I

x
e
n
n
A

n

i

d
e
t
r
e
s
n

i

e
r
a

s
e
c
n
a
t
s
b
u
s

i

g
n
w
o

l
l

o
f

e
h
T

.

A

s
e
t
i
s
a
r
a
p
o
d
n
e

t
s
n
i
a
g
a

g
n
i
t
c
a

s
t
n
e
g
A

.

1
2

.

s
t
n
e
g
a

c
i
t
i
s
a
r
a
p
i
t
n
A

.

2

t
a
f

+

i

n
k
S

e
l
c
s
u
M

y
e
n
d
K

i

r
e
v
i
L

g
k
/
g

g
k
/
g

g
k
/
g

g
k
/
g

μ

μ

μ

μ

0
5

0
5

0
0
4

0
0
3

e
n
i
c
r
o
p

,

y
r
t
l
u
o
P

-
i
z
n
e
b
-
H
1

i

o
n
m
a
-
2

(

d
n
a

e
l
o
z
a
d
n
e
b
u
l
f

f
o

m
u
S

e
n
o
n
a
h
t
e
m

)
l
y
n
e
h
p
o
r
o
u
l
f
4

(

)
l
y
-
5
-
l
o
z
a
d
m

i

e
l
o
z
a
d
n
e
b
u
l
F

‘

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

s
e
r
o
h
p
o
n
o
I

.

.

4
4
2

.

’

s
g
g
E

g
k
/
g

μ

0
0
4

y
r
t
l
u
o
P

e
l
o
z
a
d
n
e
b
u
l
F

e
l
o
z
a
d
n
e
b
u
l
F

a
o
z
o
t
o
r
p

t
s
n
i
a
g
a

g
n
i
t
c
a

s
t
n
e
g
A

.

4
2

.

t
a
f

+

i

n
k
S

e
l
c
s
u
M

’

y
e
n
d
K

i

r
e
v
i
L

g
k
/
g

g
k
/
g

g
k
/
g

g
k
/
g

μ

μ

μ

μ

0
2

0
0
1

0
0
1

0
5

y
r
t
l
u
o
P

A

d
i
c
o
l
a
s
a
L

d
i
c
o
l
a
s
a
L

‘

e
u
d
i
s
e
r

m
u
m
i
x
a
m

l
a
n
o
i
s
i
v
o
r
p

h
c
i
h
w

r
o
f

s
t
c
u
d
o
r
p

l
a
n
i
c
i
d
e
m
y
r
a
n
i
r
e
t
e
v

n

i

d
e
s
u

s
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
p

f
o

t
s
i
L
(

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I
I
I

x
e
n
n
A

n

i

d
e
t
r
e
s
n

i

s
i

e
c
n
a
t
s
b
u
s

i

g
n
w
o

l
l

o
f

e
h
T

.

B

a
o
z
o
t
o
r
p

t
s
n
i
a
g
a

g
n
i
t
c
a

s
t
n
e
g
A

.

4
2

.

s
t
n
e
g
a

c
i
t
i
s
a
r
a
p
i
t
n
A

.

2

:
)
d
e
x
i
f

n
e
e
b

e
v
a
h

s
t
i

m

i
l

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

)
1
(

s
g
g
E

g
k
/
g

μ

0
5
1

y
r
t
l
u
o
P

A

d
i
c
o
l
a
s
a
L

d
i
c
o
l
a
s
a
L

‘

’

.

8
0
0
2

y
r
a
u
n
a
J

1

n
o

e
r
i
p
x
e

s
L
R
M

l
a
n
o
i
s
i
v
o
r
P

)
1
(

s
e
r
o
h
p
o
n
o
I

.

.

5
4
2

.